Physician profile
William I Bond
NPI 1184653644
$5,068.37
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,721 · 2020: $274 · 2021: $828 · 2022: $761 · 2023: $279 · 2024: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,181.05 | 2019-2024 | Tecnis Iol |
| Alcon Vision LLC | $644.62 | 2019-2024 | Argos, Hydrus Microstent, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $416.71 | 2019-2021 | |
| Allergan, INC. | $378.57 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $319.15 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $181.53 | 2022-2024 | Vyzulta, Miebo, Envista Mx60 Iol |
| Carl Zeiss Meditec, INC. | $163.45 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $161.99 | 2021-2022 | |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Horizon Therapeutics Plc | $94.88 | 2022 | |
| Abbvie INC. | $78.66 | 2022 | |
| Novartis Pharmaceuticals Corporation | $73.94 | 2019-2023 | |
| Iridex Corporation | $65.97 | 2019 | |
| Aerie Pharmaceuticals, INC. | $51.31 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $34.88 | 2023 | Xeomin |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $25.81 | 2021 | |
| Oyster Point Pharma, INC. | $24.65 | 2022 | |
| Sun Pharmaceutical Industries INC. | $23.15 | 2023 | Cequa |
| Thea Pharma INC. | $20.10 | 2024 | Iyuzeh |
| Mallinckrodt Enterprises LLC | $20.06 | 2019 | |
| Biotissue Holdings INC. | $5.45 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.